Government of Brazil
Also known as: Brazilian National Institute of Hormones and Women's Health | Ceará Health Secretariat - SESA | Central Laboratory of Public Health of Ceara - LACEN-CE | Central Laboratory of Public Health of Ceará - Lacen-CE | CNPq Universal | Financiadora de Estudos e Projetos | INCA Brazil | INCA - Instituto Nacional de Cancer | INCA- Instituto Nacional de Câncer | InCor (HC-FMUSP) | Instituto Nacional de Cancer | Instituto Nacional de Cancer, Brazil | Instituto Nacional de Câncer Brazil | Instituto Nacional do Câncer - INCA - HCIII | Military Fire Department of the Federal District | Ministry of Health, Brazil | Ministry of Science and Technology, Brazil | Municipal Health Secretary - SMS-Fortaleza | Rio Grande do Sul State Health Department - SES/RS | Secretaria Municipal de Saúde de Bauru | Secretaria Municipal de Saúde de Guarulhos | Secretaria Nacional de Políticas sobre Drogas (SENAD) | The Ministry of Science, Technology and Innovation, Brazil
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2005Last known activity
Sep 30, 2025
Timeline
1880s
- Jan 1, 1889
Government of Brazil— Founded
Drugs by trial phase (104 distinct, 75 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (44 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Angina Pectoris
- Atherosclerosis
- Breast Diseases
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Candidiasis
- Candidiasis, Oral
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Chagas Cardiomyopathy
- Chagas Disease
- Cheilitis
- Coronavirus Infections
- Depression
- Dyslipidemias
- Fever
- Fibrosis
- Glomerulosclerosis, Focal Segmental
- Head and Neck Neoplasms
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- Hypercholesterolemia
- Hypertension
- Infections
- Influenza, Human
- Kidney Diseases
- Leishmaniasis
- Leishmaniasis, Cutaneous
- Leishmaniasis, Visceral
- Leprosy
- Leukemia
- Leukemia, Lymphoid
- Leukomalacia, Periventricular
- Leukoplakia
- Liver Cirrhosis
- Liver Diseases
- Lymphoma
- Malaria
- Malaria, Falciparum
- Malaria, Vivax
- Nausea
- Neoplasms
- Neoplasms by Site
- Pneumonia
- Pneumonia, Viral
- Postoperative Nausea and Vomiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Prehypertension
- Premature Birth
- Pressure Ulcer
- Rectal Neoplasms
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Schistosomiasis
- Severe Acute Respiratory Syndrome
- Stomatitis
- Stomatitis, Denture
- Syndrome
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Tuberculosis
- Ulcer
- Urinary Tract Infections
- Uterine Cervical Neoplasms
- Vaginal Diseases
- Vaginosis, Bacterial
- Vomiting
- Yellow Fever
Recent trials (50)
- NCT07172724CollaboratorPhase 1Sep 30, 2025
- NCT06670911Lead sponsorPhase 2Apr 2, 2025
- NCT06708702Sponsor investigatorPhase 2Dec 31, 2024
- NCT06708702Lead sponsorPhase 2Dec 31, 2024
- NCT06299462OfficialPhase 1/Phase 2Jun 20, 2024
- NCT06299462Lead sponsorPhase 1/Phase 2Jun 20, 2024
- NCT05800834Lead sponsorPhase 2Sep 12, 2023
- NCT05800834Reponsible party - principal investigatorPhase 2Sep 12, 2023
- NCT05800834Overall official - principal investigatorPhase 2Sep 12, 2023
- NCT07134725CollaboratorPhase 1/Phase 2Nov 23, 2022
- NCT05199194CollaboratorPhase 3Apr 30, 2022
- NCT04945213CollaboratorPhase 3Feb 1, 2022
- NCT05199662CollaboratorPhase 3Jan 20, 2022
- NCT05155137CollaboratorPhase 3Dec 14, 2021
- NCT05192213CollaboratorPhase 3Aug 1, 2021
Details
- Founded
- Brasília, BR Jan 1, 1889
- Last known activity
- Sep 30, 2025